Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis

Apolipoproteins (apo) C-I and C-II are key regulators of triglyceride and HDL metabolism. Both exist as full-size native and truncated (apoC-I'; apoC-II') posttranslational proteoforms. However, the determinants and the role of these proteoforms in lipid metabolism are unknown. Here, we me...

Full description

Saved in:
Bibliographic Details
Published inJournal of lipid research Vol. 63; no. 9; p. 100263
Main Authors Koska, Juraj, Furtado, Jeremy, Hu, Yueming, Sinari, Shripad, Budoff, Matthew J., Billheimer, Dean, Nedelkov, Dobrin, McClelland, Robyn L., Reaven, Peter
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.09.2022
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Apolipoproteins (apo) C-I and C-II are key regulators of triglyceride and HDL metabolism. Both exist as full-size native and truncated (apoC-I'; apoC-II') posttranslational proteoforms. However, the determinants and the role of these proteoforms in lipid metabolism are unknown. Here, we measured apoC-I and apoC-II proteoforms by mass spectrometry immunoassay in baseline and 10-year follow-up plasma samples from the Multi-Ethnic Study of Atherosclerosis. We found that baseline total apoC-I (mean = 9.2 mg/dl) was lower in African American (AA), Chinese American (CA), and Hispanic American (by 1.8; 1.0; 1.0 mg/dl vs. whites), higher in women (by 1.2 mg/dl), and positively associated with plasma triglycerides and HDL. Furthermore, we observed that the truncated-to-native apoC-I ratio (apoC-I'/C-I) was lower in CA, negatively associated with triglycerides, and positively associated with HDL. We determined that total apoC-II (8.8 mg/dl) was lower in AA (by 0.8 mg/dl) and higher in CA and Hispanic American (by 0.5 and 0.4 mg/dl), positively associated with triglycerides, and negatively associated with HDL. In addition, apoC-II'/C-II was higher in AA and women, negatively associated with triglycerides, and positively associated with HDL. We showed that the change in triglycerides was positively associated with changes in total apoC-I and apoC-II and negatively associated with changes in apoC-I'/C-I and apoC-II'/C-II, whereas the change in HDL was positively associated with changes in total apoC-I and apoC-II'/C-II and negatively associated with change in total apoC-II. This study documents racial/ethnic variation in apoC-I and apoC-II plasma levels and highlights apolipoprotein posttranslational modification as a potential regulator of plasma lipids.
AbstractList Apolipoproteins (apo) C-I and C-II are key regulators of triglyceride and HDL metabolism. Both exist as full-size native and truncated (apoC-I'; apoC-II') posttranslational proteoforms. However, the determinants and the role of these proteoforms in lipid metabolism are unknown. Here, we measured apoC-I and apoC-II proteoforms by mass spectrometry immunoassay in baseline and 10-year follow-up plasma samples from the Multi-Ethnic Study of Atherosclerosis. We found that baseline total apoC-I (mean = 9.2 mg/dl) was lower in African Americans (AA), Chinese Americans (CA), and Hispanics (by 1.8; 1.0; 1.0 mg/dl vs. whites), higher in women (by 1.2 mg/dl), and positively associated with plasma triglycerides and HDL. Furthermore, we observed that the truncated-to-native apoC-I ratio (apoC-I'/C-I) was lower in CA, negatively associated with triglycerides, and positively associated with HDL. We determined that total apoC-II (8.8 mg/dl) was lower in AA (by 0.8 mg/dl) and higher in CA and Hispanics (by 0.5 and 0.4 mg/dl), positively associated with triglycerides, and negatively associated with HDL. In addition, apoC-II'/C-II was higher in AA and women, negatively associated with triglycerides, and positively associated with HDL. We showed that the change in triglycerides was positively associated with changes in total apoC-I and apoC-II and negatively associated with changes in apoC-I'/C-I and apoC-II'/C-II, whereas the change in HDL was positively associated with changes in total apoC-I and apoC-II'/C-II and negatively associated with change in total apoC-II. This study documents racial/ethnic variation in apoC-I and apoC-II plasma levels and highlights apolipoprotein posttranslational modification as a potential regulator of plasma lipids.
Apolipoproteins (apo) C-I and C-II are key regulators of triglyceride and HDL metabolism. Both exist as full-size native and truncated (apoC-I'; apoC-II') posttranslational proteoforms. However, the determinants and the role of these proteoforms in lipid metabolism are unknown. Here, we measured apoC-I and apoC-II proteoforms by mass spectrometry immunoassay in baseline and 10-year follow-up plasma samples from the Multi-Ethnic Study of Atherosclerosis. We found that baseline total apoC-I (mean = 9.2 mg/dl) was lower in African American (AA), Chinese American (CA), and Hispanic American (by 1.8; 1.0; 1.0 mg/dl vs. whites), higher in women (by 1.2 mg/dl), and positively associated with plasma triglycerides and HDL. Furthermore, we observed that the truncated-to-native apoC-I ratio (apoC-I'/C-I) was lower in CA, negatively associated with triglycerides, and positively associated with HDL. We determined that total apoC-II (8.8 mg/dl) was lower in AA (by 0.8 mg/dl) and higher in CA and Hispanic American (by 0.5 and 0.4 mg/dl), positively associated with triglycerides, and negatively associated with HDL. In addition, apoC-II'/C-II was higher in AA and women, negatively associated with triglycerides, and positively associated with HDL. We showed that the change in triglycerides was positively associated with changes in total apoC-I and apoC-II and negatively associated with changes in apoC-I'/C-I and apoC-II'/C-II, whereas the change in HDL was positively associated with changes in total apoC-I and apoC-II'/C-II and negatively associated with change in total apoC-II. This study documents racial/ethnic variation in apoC-I and apoC-II plasma levels and highlights apolipoprotein posttranslational modification as a potential regulator of plasma lipids.
Apolipoproteins (apo) C-I and C-II are key regulators of triglyceride and HDL metabolism. Both exist as full-size native and truncated (apoC-I'; apoC-II') posttranslational proteoforms. However, the determinants and the role of these proteoforms in lipid metabolism are unknown. Here, we measured apoC-I and apoC-II proteoforms by mass spectrometry immunoassay in baseline and 10-year follow-up plasma samples from the Multi-Ethnic Study of Atherosclerosis. We found that baseline total apoC-I (mean = 9.2 mg/dl) was lower in African Americans (AA), Chinese Americans (CA), and Hispanics (by 1.8; 1.0; 1.0 mg/dl vs. whites), higher in women (by 1.2 mg/dl), and positively associated with plasma triglycerides and HDL. Furthermore, we observed that the truncated-to-native apoC-I ratio (apoC-I'/C-I) was lower in CA, negatively associated with triglycerides, and positively associated with HDL. We determined that total apoC-II (8.8 mg/dl) was lower in AA (by 0.8 mg/dl) and higher in CA and Hispanics (by 0.5 and 0.4 mg/dl), positively associated with triglycerides, and negatively associated with HDL. In addition, apoC-II'/C-II was higher in AA and women, negatively associated with triglycerides, and positively associated with HDL. We showed that the change in triglycerides was positively associated with changes in total apoC-I and apoC-II and negatively associated with changes in apoC-I'/C-I and apoC-II'/C-II, whereas the change in HDL was positively associated with changes in total apoC-I and apoC-II'/C-II and negatively associated with change in total apoC-II. This study documents racial/ethnic variation in apoC-I and apoC-II plasma levels and highlights apolipoprotein posttranslational modification as a potential regulator of plasma lipids.Apolipoproteins (apo) C-I and C-II are key regulators of triglyceride and HDL metabolism. Both exist as full-size native and truncated (apoC-I'; apoC-II') posttranslational proteoforms. However, the determinants and the role of these proteoforms in lipid metabolism are unknown. Here, we measured apoC-I and apoC-II proteoforms by mass spectrometry immunoassay in baseline and 10-year follow-up plasma samples from the Multi-Ethnic Study of Atherosclerosis. We found that baseline total apoC-I (mean = 9.2 mg/dl) was lower in African Americans (AA), Chinese Americans (CA), and Hispanics (by 1.8; 1.0; 1.0 mg/dl vs. whites), higher in women (by 1.2 mg/dl), and positively associated with plasma triglycerides and HDL. Furthermore, we observed that the truncated-to-native apoC-I ratio (apoC-I'/C-I) was lower in CA, negatively associated with triglycerides, and positively associated with HDL. We determined that total apoC-II (8.8 mg/dl) was lower in AA (by 0.8 mg/dl) and higher in CA and Hispanics (by 0.5 and 0.4 mg/dl), positively associated with triglycerides, and negatively associated with HDL. In addition, apoC-II'/C-II was higher in AA and women, negatively associated with triglycerides, and positively associated with HDL. We showed that the change in triglycerides was positively associated with changes in total apoC-I and apoC-II and negatively associated with changes in apoC-I'/C-I and apoC-II'/C-II, whereas the change in HDL was positively associated with changes in total apoC-I and apoC-II'/C-II and negatively associated with change in total apoC-II. This study documents racial/ethnic variation in apoC-I and apoC-II plasma levels and highlights apolipoprotein posttranslational modification as a potential regulator of plasma lipids.
ArticleNumber 100263
Author Koska, Juraj
Hu, Yueming
McClelland, Robyn L.
Reaven, Peter
Nedelkov, Dobrin
Furtado, Jeremy
Billheimer, Dean
Budoff, Matthew J.
Sinari, Shripad
Author_xml – sequence: 1
  givenname: Juraj
  orcidid: 0000-0002-6671-6250
  surname: Koska
  fullname: Koska, Juraj
  email: juraj.koska@va.gov
  organization: Phoenix VA Health Care System, Phoenix, AZ, USA
– sequence: 2
  givenname: Jeremy
  surname: Furtado
  fullname: Furtado, Jeremy
  organization: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA
– sequence: 3
  givenname: Yueming
  surname: Hu
  fullname: Hu, Yueming
  organization: Isoformix Inc, Phoenix, AZ, USA
– sequence: 4
  givenname: Shripad
  surname: Sinari
  fullname: Sinari, Shripad
  organization: Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA
– sequence: 5
  givenname: Matthew J.
  surname: Budoff
  fullname: Budoff, Matthew J.
  organization: Los Angeles Biomedical Research Institute, Torrance, CA, USA
– sequence: 6
  givenname: Dean
  surname: Billheimer
  fullname: Billheimer, Dean
  organization: Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA
– sequence: 7
  givenname: Dobrin
  surname: Nedelkov
  fullname: Nedelkov, Dobrin
  organization: Isoformix Inc, Phoenix, AZ, USA
– sequence: 8
  givenname: Robyn L.
  surname: McClelland
  fullname: McClelland, Robyn L.
  organization: Department of Biostatistics, University of Washington, Seattle, WA, USA
– sequence: 9
  givenname: Peter
  surname: Reaven
  fullname: Reaven, Peter
  organization: College of Health Solutions, Arizona State University, Phoenix, AZ, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35952903$$D View this record in MEDLINE/PubMed
BookMark eNp9UU1v1DAUtFAR3RZ-ABfkI5cstvPhWJyqVYGVikACzpbjD_ZFSRxsp6hH_jlOU3rgUFnye36eGVszF-hs8pNF6DUle0po867f90PYM8JYPhPWlM_QjtalKDhr2Bna5RkrGOP1ObqIsSeEVlVDX6DzshY1E6TcoT9fBxVHhefgk_XOhzFi77Ca_QCzv5_CFPGhOGI1mbXmJlisYvQaVLIG_4Z0wvMmk0lgIoYJp5PFn5chQXGdThNo_C0t5m7VvspXwUc9rDvEl-i5U0O0rx7qJfrx4fr74VNx8-Xj8XB1U-iqYangrRbU2JbrjhpXu7p1utH1uhQRxFYVLYnTylDKuGgbU6u21NRoK6rsgyov0XHTNV71cg4wqnAnvQJ5P_Dhp1QhQf6WJNrxRlSmYazLul3LHae846RlghFLs9bbTSsb9GuxMckRorbDoCbrlygZJ4yKKtudoW8eoEs3WvP48L8IMoBuAJ3tiMG6Rwglco1Z9jLHLNeY5RZz5vD_OBqSSuCnFBQMTzLfb0ybrb4FG2TUYCdtDQSrU_YCnmD_BTKtwQ4
CitedBy_id crossref_primary_10_3390_biomedicines12102403
crossref_primary_10_1371_journal_pone_0282821
crossref_primary_10_1016_j_atherosclerosis_2023_117214
crossref_primary_10_1371_journal_pone_0313625
crossref_primary_10_2337_dc24_1462
Cites_doi 10.1016/S0021-9258(18)67554-4
10.1161/CIRCRESAHA.113.300634
10.1074/jbc.M203151200
10.1194/jlr.P064816
10.1074/jbc.M113.495366
10.1194/jlr.M800588-JLR200
10.1016/j.metabol.2011.12.002
10.2337/db11-0040
10.1194/jlr.D071787
10.1016/0026-0495(79)90004-0
10.1016/0006-2944(79)90063-2
10.1016/S0021-9258(18)32773-X
10.1210/er.2014-1035
10.1097/MOL.0000000000000680
10.1001/archinte.165.12.1395
10.1161/01.CIR.0000157730.94423.4B
10.1194/jlr.M400301-JLR200
10.1093/aje/kwf113
10.1080/713609354
10.3390/ijms20235939
10.1161/01.ATV.19.3.472
10.1161/CIRCULATIONAHA.106.622514
10.1097/00041433-200106000-00009
10.1073/pnas.80.9.2574
10.1515/cclm-2017-1099
10.1006/pmed.2002.1045
10.1016/j.atherosclerosis.2017.10.025
10.1093/clinchem/18.6.499
10.1161/ATVBAHA.117.307025
10.1016/0006-291X(70)90468-7
10.3945/jn.116.242750
10.1194/jlr.P064170
10.1016/0009-8981(75)90374-5
10.1161/01.ATV.3.3.260
10.1093/clinchem/27.4.543
10.1161/ATVBAHA.107.160192
10.1111/eci.12657
10.1016/S0022-2275(20)32459-7
10.1161/ATVBAHA.109.197830
10.1007/s13300-015-0123-1
ContentType Journal Article
Copyright 2022 The Authors
Published by Elsevier Inc.
Copyright_xml – notice: 2022 The Authors
– notice: Published by Elsevier Inc.
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOA
DOI 10.1016/j.jlr.2022.100263
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Open Access Full Text
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1539-7262
ExternalDocumentID oai_doaj_org_article_0cf7694d622b441b87f717b7082920e1
35952903
10_1016_j_jlr_2022_100263
S0022227522000967
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: R01 HL138969
GroupedDBID ---
-~X
.55
.GJ
0SF
0VX
18M
29K
2WC
34G
39C
4.4
53G
5GY
5RE
5VS
6I.
AAEDW
AAFTH
AAFWJ
AAXUO
AAYOK
ABCQX
ABOCM
ACCCW
ACGFO
ACKIV
ACNCT
ACPRK
ADBBV
AENEX
AEXQZ
AFFNX
AFOSN
AFPKN
AHPSJ
AI.
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BAWUL
BTFSW
C1A
CS3
D-I
DIK
DU5
E3Z
EBS
EJD
F5P
FDB
FRP
GROUPED_DOAJ
GX1
H13
HH5
HYE
H~9
J5H
KQ8
L7B
MVM
OK1
P2P
RHF
RHI
ROL
RPM
TBC
TR2
TWZ
VH1
W8F
WH7
WOQ
X7M
XFK
YHG
YKV
ZA5
ZGI
ZXP
~KM
0R~
AALRI
AAYWO
AAYXX
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AIGII
AITUG
AKBMS
AKRWK
AKYEP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c462t-78c91de87cb1df5f58fc6c5c5c5a090e44130fcad1127986d5a83c1dce94002a3
IEDL.DBID DOA
ISSN 0022-2275
1539-7262
IngestDate Wed Aug 27 01:29:42 EDT 2025
Fri Jul 11 04:40:02 EDT 2025
Thu Jan 02 22:52:06 EST 2025
Tue Jul 01 01:31:52 EDT 2025
Thu Apr 24 23:01:00 EDT 2025
Fri Feb 23 02:40:39 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords atherosclerosis
AA
MESA
proteomics
lipid metabolism
lipid transport
DPP-4
LPL
triglycerides
race/ethnicity
TRL
HDL
GFR
cholesterol
mass spectrometry
apolipoprotein posttranslational proteoforms
apoC-I
apoC-II
CA
Language English
License This is an open access article under the CC BY license.
Published by Elsevier Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-78c91de87cb1df5f58fc6c5c5c5a090e44130fcad1127986d5a83c1dce94002a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-6671-6250
OpenAccessLink https://doaj.org/article/0cf7694d622b441b87f717b7082920e1
PMID 35952903
PQID 2702194144
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_0cf7694d622b441b87f717b7082920e1
proquest_miscellaneous_2702194144
pubmed_primary_35952903
crossref_primary_10_1016_j_jlr_2022_100263
crossref_citationtrail_10_1016_j_jlr_2022_100263
elsevier_sciencedirect_doi_10_1016_j_jlr_2022_100263
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-09-00
20220901
2022-09-01
PublicationDateYYYYMMDD 2022-09-01
PublicationDate_xml – month: 09
  year: 2022
  text: 2022-09-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of lipid research
PublicationTitleAlternate J Lipid Res
PublicationYear 2022
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Sumner, Finley, Genovese, Criqui, Boston (bib24) 2005; 165
Abbott, Garrison, Wilson, Epstein, Castelli, Feinleib (bib25) 1983; 3
Larsson, Vorrsjo, Talmud, Lookene, Olivecrona (bib27) 2013; 288
Reimund, Kovrov, Olivecrona, Lookene (bib37) 2017; 58
Zannis, Karathanasis, Keutmann, Goldberger, Breslow (bib39) 1983; 80
Wolska, Dunbar, Freeman, Ueda, Amar, Sviridov (bib2) 2017; 267
Adiels, Olofsson, Taskinen, Boren (bib35) 2008; 28
Mendivil, Zheng, Furtado, Lel, Sacks (bib18) 2010; 30
Olivieri, Chiariello, Martinelli, Castagna, Speziali, Girelli (bib15) 2018; 56
Curry, McConathy, Fesmire, Alaupovic (bib29) 1981; 27
Cyr, Wassef, Bissonnette, Lamantia, Davignon, Faraj (bib23) 2016; 57
Gerber, Goldbourt, Cohen, Harats (bib32) 2002; 35
Koska, Yassine, Trenchevska, Sinari, Schwenke, Yen (bib14) 2016; 57
Bild, Detrano, Peterson, Guerci, Liu, Shahar (bib17) 2005; 111
Schonfeld, George, Miller, Reilly, Witztum (bib33) 1979; 28
Lambeir, Durinx, Scharpe, De Meester (bib12) 2003; 40
Kawakami, Aikawa, Alcaide, Luscinskas, Libby, Sacks (bib42) 2006; 114
Mulvihill, Drucker (bib13) 2014; 35
Bild, Bluemke, Burke, Detrano, Diez Roux, Folsom (bib16) 2002; 156
LaRosa, Levy, Herbert, Lux, Fredrickson (bib6) 1970; 41
Kei, Filippatos, Tsimihodimos, Elisaf (bib8) 2012; 61
Sorensen, Sondergaard, Nellemann, Christiansen, Gormsen, Nielsen (bib34) 2011; 60
Gordon, Sims, Lentz, Edelstein, Scanu, Strauss (bib38) 1983; 258
Sacks, Jensen (bib40) 2018; 38
Ekman, Nilsson-Ehle (bib28) 1975; 63
de Barros, Boualam, Gautier, Dumont, Verges, Masson (bib30) 2009; 50
Bondarenko, Cockrill, Watkins, Cruzado, Macfarlane (bib9) 1999; 40
Shachter (bib3) 2001; 12
Jong, Hofker, Havekes (bib4) 1999; 19
Friedewald, Levy, Fredrickson (bib19) 1972; 18
Fojo, Taam, Fairwell, Ronan, Bishop, Meng (bib11) 1986; 261
Wolska, Reimund, Remaley (bib7) 2020; 31
Oldoni, Sinke, Kuivenhoven (bib41) 2014; 114
Hansen, Fernandez, Noto, Deguchi, Bjorkegren, Mathiesen (bib21) 2011; 2011
Wassef, Bissonnette, Dufour, Davignon, Faraj (bib22) 2017; 147
Gautier, Masson, Jong, Duverneuil, Le Guern, Deckert (bib31) 2002; 277
Fuior, Gafencu (bib1) 2019; 20
Havel, Kotite, Kane (bib5) 1979; 21
Berbee, van der Hoogt, Sundararaman, Havekes, Rensen (bib26) 2005; 46
Hu, Meuret, Martinez, Yassine, Nedelkov (bib10) 2020; 62
Skinner, Wroblewski, Kirihara, Nelsestuen, Seaquist (bib20) 2015; 6
Ooi, Chan, Hodson, Adiels, Boren, Karpe (bib36) 2016; 46
Jong (10.1016/j.jlr.2022.100263_bib4) 1999; 19
Abbott (10.1016/j.jlr.2022.100263_bib25) 1983; 3
Wassef (10.1016/j.jlr.2022.100263_bib22) 2017; 147
Schonfeld (10.1016/j.jlr.2022.100263_bib33) 1979; 28
Larsson (10.1016/j.jlr.2022.100263_bib27) 2013; 288
Gordon (10.1016/j.jlr.2022.100263_bib38) 1983; 258
Olivieri (10.1016/j.jlr.2022.100263_bib15) 2018; 56
Bild (10.1016/j.jlr.2022.100263_bib16) 2002; 156
Skinner (10.1016/j.jlr.2022.100263_bib20) 2015; 6
Sumner (10.1016/j.jlr.2022.100263_bib24) 2005; 165
Cyr (10.1016/j.jlr.2022.100263_bib23) 2016; 57
Friedewald (10.1016/j.jlr.2022.100263_bib19) 1972; 18
Sacks (10.1016/j.jlr.2022.100263_bib40) 2018; 38
Wolska (10.1016/j.jlr.2022.100263_bib2) 2017; 267
Reimund (10.1016/j.jlr.2022.100263_bib37) 2017; 58
de Barros (10.1016/j.jlr.2022.100263_bib30) 2009; 50
Oldoni (10.1016/j.jlr.2022.100263_bib41) 2014; 114
Lambeir (10.1016/j.jlr.2022.100263_bib12) 2003; 40
Berbee (10.1016/j.jlr.2022.100263_bib26) 2005; 46
Ekman (10.1016/j.jlr.2022.100263_bib28) 1975; 63
Adiels (10.1016/j.jlr.2022.100263_bib35) 2008; 28
Hu (10.1016/j.jlr.2022.100263_bib10) 2020; 62
Koska (10.1016/j.jlr.2022.100263_bib14) 2016; 57
Mendivil (10.1016/j.jlr.2022.100263_bib18) 2010; 30
Zannis (10.1016/j.jlr.2022.100263_bib39) 1983; 80
Mulvihill (10.1016/j.jlr.2022.100263_bib13) 2014; 35
Ooi (10.1016/j.jlr.2022.100263_bib36) 2016; 46
Fuior (10.1016/j.jlr.2022.100263_bib1) 2019; 20
Kei (10.1016/j.jlr.2022.100263_bib8) 2012; 61
Bild (10.1016/j.jlr.2022.100263_bib17) 2005; 111
Havel (10.1016/j.jlr.2022.100263_bib5) 1979; 21
LaRosa (10.1016/j.jlr.2022.100263_bib6) 1970; 41
Gautier (10.1016/j.jlr.2022.100263_bib31) 2002; 277
Kawakami (10.1016/j.jlr.2022.100263_bib42) 2006; 114
Wolska (10.1016/j.jlr.2022.100263_bib7) 2020; 31
Sorensen (10.1016/j.jlr.2022.100263_bib34) 2011; 60
Curry (10.1016/j.jlr.2022.100263_bib29) 1981; 27
Bondarenko (10.1016/j.jlr.2022.100263_bib9) 1999; 40
Hansen (10.1016/j.jlr.2022.100263_bib21) 2011; 2011
Fojo (10.1016/j.jlr.2022.100263_bib11) 1986; 261
Gerber (10.1016/j.jlr.2022.100263_bib32) 2002; 35
Shachter (10.1016/j.jlr.2022.100263_bib3) 2001; 12
References_xml – volume: 35
  start-page: 992
  year: 2014
  end-page: 1019
  ident: bib13
  article-title: Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors
  publication-title: Endocr. Rev.
– volume: 21
  start-page: 121
  year: 1979
  end-page: 138
  ident: bib5
  article-title: Isoelectric heterogeneity of the cofactor protein for lipoprotein lipase in human blood plasma
  publication-title: Biochem. Med.
– volume: 267
  start-page: 49
  year: 2017
  end-page: 60
  ident: bib2
  article-title: Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism
  publication-title: Atherosclerosis
– volume: 12
  start-page: 297
  year: 2001
  end-page: 304
  ident: bib3
  article-title: Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism
  publication-title: Curr. Opin. Lipidol.
– volume: 288
  start-page: 33997
  year: 2013
  end-page: 34008
  ident: bib27
  article-title: Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets
  publication-title: J. Biol. Chem.
– volume: 40
  start-page: 209
  year: 2003
  end-page: 294
  ident: bib12
  article-title: Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV
  publication-title: Crit. Rev. Clin. Lab. Sci.
– volume: 28
  start-page: 1225
  year: 2008
  end-page: 1236
  ident: bib35
  article-title: Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 56
  start-page: 1542
  year: 2018
  end-page: 1550
  ident: bib15
  article-title: Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease
  publication-title: Clin. Chem. Lab. Med.
– volume: 61
  start-page: 906
  year: 2012
  end-page: 921
  ident: bib8
  article-title: A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease
  publication-title: Metabolism
– volume: 40
  start-page: 543
  year: 1999
  end-page: 555
  ident: bib9
  article-title: Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein
  publication-title: J. Lipid Res.
– volume: 165
  start-page: 1395
  year: 2005
  end-page: 1400
  ident: bib24
  article-title: Fasting triglyceride and the triglyceride–HDL cholesterol ratio are not markers of insulin resistance in African Americans
  publication-title: Arch. Intern. Med.
– volume: 6
  start-page: 395
  year: 2015
  end-page: 401
  ident: bib20
  article-title: Sitagliptin results in a decrease of truncated apolipoprotein C1
  publication-title: Diabetes Ther.
– volume: 3
  start-page: 260
  year: 1983
  end-page: 272
  ident: bib25
  article-title: Joint distribution of lipoprotein cholesterol classes. The Framingham study
  publication-title: Arteriosclerosis
– volume: 30
  start-page: 239
  year: 2010
  end-page: 245
  ident: bib18
  article-title: Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 147
  start-page: 754
  year: 2017
  end-page: 762
  ident: bib22
  article-title: Enrichment of triglyceride-rich lipoproteins with apolipoprotein C-I is positively associated with their delayed plasma clearance independently of other transferable apolipoproteins in postmenopausal overweight and obese women
  publication-title: J. Nutr.
– volume: 50
  start-page: 1842
  year: 2009
  end-page: 1851
  ident: bib30
  article-title: Apolipoprotein CI is a physiological regulator of cholesteryl ester transfer protein activity in human plasma but not in rabbit plasma
  publication-title: J. Lipid Res.
– volume: 58
  start-page: 279
  year: 2017
  end-page: 288
  ident: bib37
  article-title: Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry
  publication-title: J. Lipid Res.
– volume: 46
  start-page: 297
  year: 2005
  end-page: 306
  ident: bib26
  article-title: Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL
  publication-title: J. Lipid Res.
– volume: 57
  start-page: 1074
  year: 2016
  end-page: 1085
  ident: bib23
  article-title: WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects
  publication-title: J. Lipid Res.
– volume: 63
  start-page: 29
  year: 1975
  end-page: 35
  ident: bib28
  article-title: Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue
  publication-title: Clin. Chim. Acta
– volume: 60
  start-page: 2257
  year: 2011
  end-page: 2264
  ident: bib34
  article-title: Increased VLDL-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men
  publication-title: Diabetes
– volume: 19
  start-page: 472
  year: 1999
  end-page: 484
  ident: bib4
  article-title: Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 27
  start-page: 543
  year: 1981
  end-page: 548
  ident: bib29
  article-title: Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays
  publication-title: Clin. Chem.
– volume: 18
  start-page: 499
  year: 1972
  end-page: 502
  ident: bib19
  article-title: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
  publication-title: Clin. Chem.
– volume: 57
  start-page: 894
  year: 2016
  end-page: 905
  ident: bib14
  article-title: Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes
  publication-title: J. Lipid Res.
– volume: 38
  start-page: 487
  year: 2018
  end-page: 499
  ident: bib40
  article-title: From high-density lipoprotein cholesterol to measurements of function: prospects for the development of tests for high-density lipoprotein functionality in cardiovascular disease
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 62
  year: 2020
  ident: bib10
  article-title: Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer's disease
  publication-title: J. Lipid Res.
– volume: 156
  start-page: 871
  year: 2002
  end-page: 881
  ident: bib16
  article-title: Multi-ethnic study of atherosclerosis: objectives and design
  publication-title: Am. J. Epidemiol.
– volume: 114
  start-page: 124
  year: 2014
  end-page: 142
  ident: bib41
  article-title: Mendelian disorders of high-density lipoprotein metabolism
  publication-title: Circ. Res.
– volume: 20
  start-page: 5939
  year: 2019
  ident: bib1
  article-title: Apolipoprotein C1: its pleiotropic effects in lipid metabolism and beyond
  publication-title: Int. J. Mol. Sci.
– volume: 258
  start-page: 4037
  year: 1983
  end-page: 4044
  ident: bib38
  article-title: Proteolytic processing of human preproapolipoprotein A-I. A proposed defect in the conversion of pro A-I to A-I in Tangier's disease
  publication-title: J. Biol. Chem.
– volume: 35
  start-page: 42
  year: 2002
  end-page: 47
  ident: bib32
  article-title: Association between serum apolipoprotein C(II) concentration and coronary heart disease
  publication-title: Prev. Med.
– volume: 41
  start-page: 57
  year: 1970
  end-page: 62
  ident: bib6
  article-title: A specific apoprotein activator for lipoprotein lipase
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 261
  start-page: 9591
  year: 1986
  end-page: 9594
  ident: bib11
  article-title: Human preproapolipoprotein C-II. Analysis of major plasma isoforms
  publication-title: J. Biol. Chem.
– volume: 111
  start-page: 1313
  year: 2005
  end-page: 1320
  ident: bib17
  article-title: Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA)
  publication-title: Circulation
– volume: 46
  start-page: 730
  year: 2016
  end-page: 736
  ident: bib36
  article-title: Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III
  publication-title: Eur. J. Clin. Invest.
– volume: 80
  start-page: 2574
  year: 1983
  end-page: 2578
  ident: bib39
  article-title: Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 114
  start-page: 681
  year: 2006
  end-page: 687
  ident: bib42
  article-title: Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells
  publication-title: Circulation
– volume: 2011
  year: 2011
  ident: bib21
  article-title: The apolipoprotein C-I content of very-low-density lipoproteins is associated with fasting triglycerides, postprandial lipemia, and carotid atherosclerosis
  publication-title: J. Lipids
– volume: 277
  start-page: 31354
  year: 2002
  end-page: 31363
  ident: bib31
  article-title: Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice
  publication-title: J. Biol. Chem.
– volume: 28
  start-page: 1001
  year: 1979
  end-page: 1010
  ident: bib33
  article-title: Apolipoprotein C-II and C-III levels in hyperlipoproteinemia
  publication-title: Metabolism
– volume: 31
  start-page: 147
  year: 2020
  end-page: 153
  ident: bib7
  article-title: Apolipoprotein C-II: the re-emergence of a forgotten factor
  publication-title: Curr. Opin. Lipidol.
– volume: 261
  start-page: 9591
  year: 1986
  ident: 10.1016/j.jlr.2022.100263_bib11
  article-title: Human preproapolipoprotein C-II. Analysis of major plasma isoforms
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)67554-4
– volume: 114
  start-page: 124
  year: 2014
  ident: 10.1016/j.jlr.2022.100263_bib41
  article-title: Mendelian disorders of high-density lipoprotein metabolism
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.113.300634
– volume: 277
  start-page: 31354
  year: 2002
  ident: 10.1016/j.jlr.2022.100263_bib31
  article-title: Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M203151200
– volume: 57
  start-page: 894
  year: 2016
  ident: 10.1016/j.jlr.2022.100263_bib14
  article-title: Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.P064816
– volume: 288
  start-page: 33997
  year: 2013
  ident: 10.1016/j.jlr.2022.100263_bib27
  article-title: Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M113.495366
– volume: 2011
  year: 2011
  ident: 10.1016/j.jlr.2022.100263_bib21
  article-title: The apolipoprotein C-I content of very-low-density lipoproteins is associated with fasting triglycerides, postprandial lipemia, and carotid atherosclerosis
  publication-title: J. Lipids
– volume: 50
  start-page: 1842
  year: 2009
  ident: 10.1016/j.jlr.2022.100263_bib30
  article-title: Apolipoprotein CI is a physiological regulator of cholesteryl ester transfer protein activity in human plasma but not in rabbit plasma
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.M800588-JLR200
– volume: 61
  start-page: 906
  year: 2012
  ident: 10.1016/j.jlr.2022.100263_bib8
  article-title: A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2011.12.002
– volume: 60
  start-page: 2257
  year: 2011
  ident: 10.1016/j.jlr.2022.100263_bib34
  article-title: Increased VLDL-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men
  publication-title: Diabetes
  doi: 10.2337/db11-0040
– volume: 58
  start-page: 279
  year: 2017
  ident: 10.1016/j.jlr.2022.100263_bib37
  article-title: Lipoprotein lipase activity and interactions studied in human plasma by isothermal titration calorimetry
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.D071787
– volume: 28
  start-page: 1001
  year: 1979
  ident: 10.1016/j.jlr.2022.100263_bib33
  article-title: Apolipoprotein C-II and C-III levels in hyperlipoproteinemia
  publication-title: Metabolism
  doi: 10.1016/0026-0495(79)90004-0
– volume: 21
  start-page: 121
  year: 1979
  ident: 10.1016/j.jlr.2022.100263_bib5
  article-title: Isoelectric heterogeneity of the cofactor protein for lipoprotein lipase in human blood plasma
  publication-title: Biochem. Med.
  doi: 10.1016/0006-2944(79)90063-2
– volume: 258
  start-page: 4037
  year: 1983
  ident: 10.1016/j.jlr.2022.100263_bib38
  article-title: Proteolytic processing of human preproapolipoprotein A-I. A proposed defect in the conversion of pro A-I to A-I in Tangier's disease
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(18)32773-X
– volume: 35
  start-page: 992
  year: 2014
  ident: 10.1016/j.jlr.2022.100263_bib13
  article-title: Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors
  publication-title: Endocr. Rev.
  doi: 10.1210/er.2014-1035
– volume: 31
  start-page: 147
  year: 2020
  ident: 10.1016/j.jlr.2022.100263_bib7
  article-title: Apolipoprotein C-II: the re-emergence of a forgotten factor
  publication-title: Curr. Opin. Lipidol.
  doi: 10.1097/MOL.0000000000000680
– volume: 165
  start-page: 1395
  year: 2005
  ident: 10.1016/j.jlr.2022.100263_bib24
  article-title: Fasting triglyceride and the triglyceride–HDL cholesterol ratio are not markers of insulin resistance in African Americans
  publication-title: Arch. Intern. Med.
  doi: 10.1001/archinte.165.12.1395
– volume: 111
  start-page: 1313
  year: 2005
  ident: 10.1016/j.jlr.2022.100263_bib17
  article-title: Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA)
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000157730.94423.4B
– volume: 46
  start-page: 297
  year: 2005
  ident: 10.1016/j.jlr.2022.100263_bib26
  article-title: Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.M400301-JLR200
– volume: 156
  start-page: 871
  year: 2002
  ident: 10.1016/j.jlr.2022.100263_bib16
  article-title: Multi-ethnic study of atherosclerosis: objectives and design
  publication-title: Am. J. Epidemiol.
  doi: 10.1093/aje/kwf113
– volume: 40
  start-page: 209
  year: 2003
  ident: 10.1016/j.jlr.2022.100263_bib12
  article-title: Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV
  publication-title: Crit. Rev. Clin. Lab. Sci.
  doi: 10.1080/713609354
– volume: 20
  start-page: 5939
  year: 2019
  ident: 10.1016/j.jlr.2022.100263_bib1
  article-title: Apolipoprotein C1: its pleiotropic effects in lipid metabolism and beyond
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms20235939
– volume: 19
  start-page: 472
  year: 1999
  ident: 10.1016/j.jlr.2022.100263_bib4
  article-title: Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.19.3.472
– volume: 114
  start-page: 681
  year: 2006
  ident: 10.1016/j.jlr.2022.100263_bib42
  article-title: Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.106.622514
– volume: 12
  start-page: 297
  year: 2001
  ident: 10.1016/j.jlr.2022.100263_bib3
  article-title: Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism
  publication-title: Curr. Opin. Lipidol.
  doi: 10.1097/00041433-200106000-00009
– volume: 80
  start-page: 2574
  year: 1983
  ident: 10.1016/j.jlr.2022.100263_bib39
  article-title: Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.80.9.2574
– volume: 56
  start-page: 1542
  year: 2018
  ident: 10.1016/j.jlr.2022.100263_bib15
  article-title: Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease
  publication-title: Clin. Chem. Lab. Med.
  doi: 10.1515/cclm-2017-1099
– volume: 35
  start-page: 42
  year: 2002
  ident: 10.1016/j.jlr.2022.100263_bib32
  article-title: Association between serum apolipoprotein C(II) concentration and coronary heart disease
  publication-title: Prev. Med.
  doi: 10.1006/pmed.2002.1045
– volume: 267
  start-page: 49
  year: 2017
  ident: 10.1016/j.jlr.2022.100263_bib2
  article-title: Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2017.10.025
– volume: 18
  start-page: 499
  year: 1972
  ident: 10.1016/j.jlr.2022.100263_bib19
  article-title: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
  publication-title: Clin. Chem.
  doi: 10.1093/clinchem/18.6.499
– volume: 38
  start-page: 487
  year: 2018
  ident: 10.1016/j.jlr.2022.100263_bib40
  article-title: From high-density lipoprotein cholesterol to measurements of function: prospects for the development of tests for high-density lipoprotein functionality in cardiovascular disease
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.117.307025
– volume: 41
  start-page: 57
  year: 1970
  ident: 10.1016/j.jlr.2022.100263_bib6
  article-title: A specific apoprotein activator for lipoprotein lipase
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/0006-291X(70)90468-7
– volume: 147
  start-page: 754
  year: 2017
  ident: 10.1016/j.jlr.2022.100263_bib22
  article-title: Enrichment of triglyceride-rich lipoproteins with apolipoprotein C-I is positively associated with their delayed plasma clearance independently of other transferable apolipoproteins in postmenopausal overweight and obese women
  publication-title: J. Nutr.
  doi: 10.3945/jn.116.242750
– volume: 57
  start-page: 1074
  year: 2016
  ident: 10.1016/j.jlr.2022.100263_bib23
  article-title: WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.P064170
– volume: 63
  start-page: 29
  year: 1975
  ident: 10.1016/j.jlr.2022.100263_bib28
  article-title: Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue
  publication-title: Clin. Chim. Acta
  doi: 10.1016/0009-8981(75)90374-5
– volume: 3
  start-page: 260
  year: 1983
  ident: 10.1016/j.jlr.2022.100263_bib25
  article-title: Joint distribution of lipoprotein cholesterol classes. The Framingham study
  publication-title: Arteriosclerosis
  doi: 10.1161/01.ATV.3.3.260
– volume: 27
  start-page: 543
  year: 1981
  ident: 10.1016/j.jlr.2022.100263_bib29
  article-title: Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays
  publication-title: Clin. Chem.
  doi: 10.1093/clinchem/27.4.543
– volume: 28
  start-page: 1225
  year: 2008
  ident: 10.1016/j.jlr.2022.100263_bib35
  article-title: Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.107.160192
– volume: 46
  start-page: 730
  year: 2016
  ident: 10.1016/j.jlr.2022.100263_bib36
  article-title: Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III
  publication-title: Eur. J. Clin. Invest.
  doi: 10.1111/eci.12657
– volume: 62
  year: 2020
  ident: 10.1016/j.jlr.2022.100263_bib10
  article-title: Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer's disease
  publication-title: J. Lipid Res.
– volume: 40
  start-page: 543
  year: 1999
  ident: 10.1016/j.jlr.2022.100263_bib9
  article-title: Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein
  publication-title: J. Lipid Res.
  doi: 10.1016/S0022-2275(20)32459-7
– volume: 30
  start-page: 239
  year: 2010
  ident: 10.1016/j.jlr.2022.100263_bib18
  article-title: Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.109.197830
– volume: 6
  start-page: 395
  year: 2015
  ident: 10.1016/j.jlr.2022.100263_bib20
  article-title: Sitagliptin results in a decrease of truncated apolipoprotein C1
  publication-title: Diabetes Ther.
  doi: 10.1007/s13300-015-0123-1
SSID ssj0014461
Score 2.4286816
Snippet Apolipoproteins (apo) C-I and C-II are key regulators of triglyceride and HDL metabolism. Both exist as full-size native and truncated (apoC-I'; apoC-II')...
SourceID doaj
proquest
pubmed
crossref
elsevier
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 100263
SubjectTerms Apolipoprotein C-II
Apolipoprotein C-III
apolipoprotein posttranslational proteoforms
Apolipoproteins
Atherosclerosis
cholesterol
Female
HDL
Humans
lipid metabolism
lipid transport
mass spectrometry
proteomics
race/ethnicity
Triglycerides
Title Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis
URI https://dx.doi.org/10.1016/j.jlr.2022.100263
https://www.ncbi.nlm.nih.gov/pubmed/35952903
https://www.proquest.com/docview/2702194144
https://doaj.org/article/0cf7694d622b441b87f717b7082920e1
Volume 63
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlPbSX0iZ9bJsEFUoPBVNblmXruFnyaAOllIbuTehl6pDIS7w55Nh_nhnJXppD00sw2MZY8uAZM99YM98Q8kFoqSusbrdO2ozbQmbGCJFxbxm3uHJkYoLsN3Fyxr8uq-Vfrb4wJyzRA6cX9zm3bS0kd4IxA67bNHULEYipsSaU5T4GPuDzpmBqXD-AIKeYeMIZq6tpPTNmdp1fIBEoY5F-VJR3PFIk7r_jmP4FPKMDOnpOno3Ikc6TxC_IIx-2yc48QNR8eUM_0pjLGX-Sb5Mni6mP2w758x0A8qWmkZGhR4w60L6lGtszrPp4tQsDXWRfqA4Oj3By5akeFecdxZ-1dJWmgUGdG2gXKEBHGut3s8P179BZijmJNzj3HFFlP4CYsO-Gl-Ts6PDn4iQbGy9klgu2zurGysL5pramcG3VVk1rha1w07nMPUfP11rtAKzVshGu0k1pC2c9tllnunxFtkIf_BtC61zLCiCoK7Gxic9lA-NLAB6yNYAlixnJp5ev7MhKjs0xLtSUfnauQF8K9aWSvmbk02bIKlFy3HfzAWp0cyOyaccLYGNqtDH1PxubET7ZgxqBSQIcMFV337PfT7ajQOe4EqOD768HhUWAheRgpjPyOhnVRkKslGYyL98-hOTvyFMUKCXF7ZKt9dW13wMUtTb75PH89Mev0_344cD-eFncAku_F1g
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Plasma+proteoforms+of+apolipoproteins+C-I+and+C-II+are+associated+with+plasma+lipids+in+the+Multi-Ethnic+Study+of+Atherosclerosis&rft.jtitle=Journal+of+lipid+research&rft.au=Koska%2C+Juraj&rft.au=Furtado%2C+Jeremy&rft.au=Hu%2C+Yueming&rft.au=Sinari%2C+Shripad&rft.date=2022-09-01&rft.issn=0022-2275&rft.volume=63&rft.issue=9&rft.spage=100263&rft_id=info:doi/10.1016%2Fj.jlr.2022.100263&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jlr_2022_100263
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2275&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2275&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2275&client=summon